Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 546 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others

ORIGINAL ARTICLE

Soluble CD30 in renal transplant recipients: Is it a good biomarker to predict rejection?

Azarpira Negar, Aghdaie Mahdokht Hosein, Malekpour Zahra

Year : 2010| Volume: 21| Issue : 1 | Page no: 31-36

   This article has been cited by
 
1 Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant
Shooshtarizadeh, T. and Mohammadali, A. and Ossareh, S. and Ataipour, Y.
Experimental and Clinical Transplantation. 2013; 11(3): 229-233
[Pubmed]  [Google Scholar]
2 Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: A meta-analysis
Chen, Y. and Tai, Q. and Hong, S. and Kong, Y. and Shang, Y. and Liang, W. and Guo, Z. and He, X.
Transplantation. 2012; 94(9): 911-918
[Pubmed]  [Google Scholar]
3 Biomarkers as a tool for management of immunosuppression in transplant patients
Wieland, E. and Olbricht, C.J. and Süsal, C. and Gurragchaa, P. and Böhler, T. and Israeli, M. and Sommerer, C. and Budde, K. and Hartmann, B. and Shipkova, M. and Oellerich, M.
Therapeutic Drug Monitoring. 2010; 32(5): 560-572
[Pubmed]  [Google Scholar]

 

Read this article